JP2024529022A - 心的外傷後ストレス障害を治療する方法 - Google Patents

心的外傷後ストレス障害を治療する方法 Download PDF

Info

Publication number
JP2024529022A
JP2024529022A JP2024506897A JP2024506897A JP2024529022A JP 2024529022 A JP2024529022 A JP 2024529022A JP 2024506897 A JP2024506897 A JP 2024506897A JP 2024506897 A JP2024506897 A JP 2024506897A JP 2024529022 A JP2024529022 A JP 2024529022A
Authority
JP
Japan
Prior art keywords
compound
individual
treatment
ptsd
dosage form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024506897A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024529022A5 (https=
Inventor
バブソン，キンバリー
Original Assignee
ジャズ ファーマシューティカルズ アイルランド リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ジャズ ファーマシューティカルズ アイルランド リミテッド filed Critical ジャズ ファーマシューティカルズ アイルランド リミテッド
Publication of JP2024529022A publication Critical patent/JP2024529022A/ja
Publication of JP2024529022A5 publication Critical patent/JP2024529022A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2024506897A 2021-08-04 2022-08-03 心的外傷後ストレス障害を治療する方法 Pending JP2024529022A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163229387P 2021-08-04 2021-08-04
US63/229,387 2021-08-04
PCT/US2022/074469 WO2023015206A1 (en) 2021-08-04 2022-08-03 Method of treating posttraumatic stress disorder

Publications (2)

Publication Number Publication Date
JP2024529022A true JP2024529022A (ja) 2024-08-01
JP2024529022A5 JP2024529022A5 (https=) 2025-03-06

Family

ID=83149040

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024506897A Pending JP2024529022A (ja) 2021-08-04 2022-08-03 心的外傷後ストレス障害を治療する方法

Country Status (10)

Country Link
US (1) US20240335441A1 (https=)
EP (1) EP4380571A1 (https=)
JP (1) JP2024529022A (https=)
KR (1) KR20240046737A (https=)
CN (1) CN118284419A (https=)
AU (1) AU2022323513A1 (https=)
CA (1) CA3227681A1 (https=)
MX (1) MX2024001673A (https=)
TW (1) TW202320779A (https=)
WO (1) WO2023015206A1 (https=)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602007011793D1 (de) * 2006-10-18 2011-02-17 Pfizer Prod Inc Biaryl-ether-harnstoffverbindungen

Also Published As

Publication number Publication date
WO2023015206A1 (en) 2023-02-09
MX2024001673A (es) 2024-04-30
CA3227681A1 (en) 2023-02-09
TW202320779A (zh) 2023-06-01
CN118284419A (zh) 2024-07-02
AU2022323513A1 (en) 2024-02-22
KR20240046737A (ko) 2024-04-09
US20240335441A1 (en) 2024-10-10
EP4380571A1 (en) 2024-06-12

Similar Documents

Publication Publication Date Title
US20220226262A1 (en) Methods of treating doose syndrome using fenfluramine
US20230093150A1 (en) Changing cognitive function with fenfluramine
AU2016312526B2 (en) Methods of treating lennox-gastaut syndrome using fenfluramine
US20180338960A1 (en) Methods of treating developmental disorders with gaboxadol
US20210299064A1 (en) Method of treating patients with lennox-gastaut syndrome
CN105832733A (zh) 高剂量拉喹莫德(laquinimod)用于治疗多发性硬化症的用途
Malcolm et al. A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence
KR20210039419A (ko) 편두통 예방을 위한 라스미디탄의 만성 야간 투여
US20090054414A1 (en) Rufinamide for the Treatment of Post-Traumatic Stress Disorder
KR20120050512A (ko) 탈수초를 갖는 환자에서 ４-아미노피리딘을 사용한 지속적 치료
Roth et al. Efficacy and safety of doxepin 6 mg in a model of transient insomnia
Mateen et al. Areca catechu (palm tree) nut chewing and seizures: An observational study
JP2024529022A (ja) 心的外傷後ストレス障害を治療する方法
US20240082215A1 (en) Use of mglur5 antagonists for treating gambling disorder
Ozyurt et al. Investigating the potential link between bruxism and obsessive-compulsive symptomatology: An exploratory study
Dhanya et al. Use of the hospital anxiety and depression scale in patients with oral lichen planus: an institutional experience
Praveen A Comparative Study to Evaluate the Efficacy and Safety of Levetiracetam as Add-On to Carbamazepine and Phenytoin in Focal Seizures at a Tertiary Care Hospital
US20250375417A1 (en) Orexin receptor 2 (ox2r) agonist for use in narcolepsy type 1 (nt1)
US20250325571A1 (en) Treatment of binge eating disorder using psychedelics
Skrumsager et al. Femoxetine and Amitriptyline in General Practice*: A Randomized Double-Blind Group Comparison
Gilmore Antidepressants, circadian rhythms, and cognition: The effects of SSRIs and SNRIs on circadian rhythms and cognitive performance
Flo-Groeneboom et al. The longitudinal association between the use of antihypertensive drugs and 24-hour sleep in nursing homes. Results from the randomized controlled COSMOS trial
Demetriou et al. Outpatient Intravenous Ketamine Protocol for Psychiatric Care at the General Hospital of Corfu
Dousset et al. The impact of anti-craving medication on cue reactivity and abstinence in patients undergoing alcohol detoxification: some preliminary evidence from a retrospective event-related potentials study
Conley et al. Safety, tolerability, pharmacokinetic and pharmacodynamic effects of the muscarinic M

Legal Events

Date Code Title Description
RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20240730

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20240730

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250225

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250715